We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
HeraMED accepts $1.02m private placement from three leading institutional investors Latest investme...
Read ArticleHighlights Prospech reports assay results with stock up by over 14%. Hera Med secures investme...
Read ArticleProspech (ASX:PRS) has announced further assay results from the ongoing program of sampling and as...
Read ArticleWorld Health Organsiation projects a shortfall of 10 million health workers by 2030 HeraMED’s platf...
Read ArticleCSL expects to be able to taper back on capital spending – at least for the time being Heramed repo...
Read ArticleASX edges slightly up by 0.12pc as traders rethink rate cuts Consumer staples shine while gold min...
Read ArticleASX closes higher led by strong mining sector Wisetech and Mineral Resources suffer heavy losses a...
Read ArticleHeraMED has recorded more than 3800 accumulated mothers onto its HeraCARE platform More than 710 p...
Read ArticleHeraMED Limited (ASX:HMD), has announced the “soft launch” of HeraCARE within the Telstra Health eco...
Read ArticleASX closes lower, but Energy sector blinks green Uranium mining stocks surged on Peter Dutton’s nuc...
Read ArticleDigital maternity care specialist HeraMED (ASX: HMD) continues to attract strong support for its uni...
Read Article19 Jun 2024 - A snapshot of the stocks on the move, featuring HeraMED (ASX:HMD), Chariot Corporation...
Read ArticleTo register for Friday's webinar click here. HeraMED (ASX:HMD) has reached a record number of accu...
Read ArticleAussie stocks start the week flat; energy and tech sectors lead declines Investor caution prevails...
Read ArticleAussie shares slipped over 1pc after the King’s Birthday long weekend Mining and Real Estate sector...
Read ArticleAussie shares rally Rate sensitive stocks gain, led by Tech FTL soars on Newfoundland deal Aussi...
Read ArticleThe ASX200 is trading up just over half a per cent. Most sectors are in the green, Healthcare is...
Read ArticleStockhead’s Top 10 at 10, published each trading day, highlights the best (and worst) performing ASX...
Read ArticleHeraMED (ASX:HMD) shares are surging following the announcement of a partnership agreement with Tels...
Read ArticlePainChek’s European patent HeraMed signs deal with Telstra AdAlta announced interim Phase 1 results...
Read ArticleThe Week That Was The world looks very different this week after the addition of what Barclays econo...
Read ArticleHeraMED (HMD) taps both sophisticated and professional investors for $2.58 million through a private...
Read ArticleASX dips 0.56% despite a solid kickstart first thing this morning InfoTech outperforms the market a...
Read ArticleAfter a more promising start, the ASX closed out the day up by 0.25%. InfoTech did well (+0.96%), b...
Read ArticleHeraMED’s partner E-Lōvu Health signs first three-year deal CareTeq has also signed a deal with the...
Read ArticleS&P/ASX 200 closes up 1% – its best performance in about a week All sectors bar IT and Utiliti...
Read ArticleParadigm Bio says drug is effective in osteoarthritic dogs HeraMED signed a deal with Fond, a US-ba...
Read ArticleHeramed surged 10pc after signing up a leading private obstetrics Ecofibre has received two patent...
Read ArticleHeraMED (HMD) signs a new contract with Joondalup Obstetrics and Gynaecology Group (JOGG) in Western...
Read ArticleHeraMED (HMD) announces Gold Coast Hospital will trial its ‘HeraCARE’ platform as its new standard o...
Read ArticleMedical data and technology company HeraMED (ASX:HMD) has announced that it has signed a mem...
Read ArticleHeraMED’s first commercial rollout in the US is progressing well Recce Pharma is set to commence Ph...
Read ArticleHeraMED (HMD) appoints former Nanosonics (NAN) Senior VP, North America, Keith Koby as its President...
Read ArticleRace Oncology received positive feedback from the US FDA HeraMed launches HeraCARE in Victoria Meso...
Read ArticleHeraMED (HMD) completes a $4 million private placement to fund early commercialisation initiatives...
Read ArticleSmall caps and benchmark down over 1% All sectors retreat on ill-winds blowing in from the states T...
Read ArticlePregnancy technology company HeraMED (HMD) enters a trading halt as the company prepares to underta...
Read ArticleHeraMed signs US deal worth $500k Pregnancy medtech specialist, HeraMed (ASX:HMD), was up over 20% t...
Read ArticleHeraMED (HMD) partners with e-Lōvu Health to supply its HeraCARE remote pregnancy monitoring techno...
Read ArticleASX is set to open higher on Thursday The US Fed raises key rate by 75bp Fed Chair Powell says the...
Read ArticlePregnancy technology company HeraMED (HMD) completes the HeraBEAT clinical trial with Israel’s Sheb...
Read ArticleBenchmark down, small caps up Utilities ahead 1% and well, the energy sector is on fire And why ear...
Read ArticleHeraMED’s device is effective for telemedicine in monitoring pregnant women Mesoblast issues strong...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleHighlights Virtual OB paid pilot of HeraMED in partnership with Pediatrix® Medical Group receiv...
Read ArticleASX health stocks (XHJ index) are down .99% today but faring better than the ASX 200 which has falle...
Read ArticleDigital maternity care company HeraMED (HMD) has hit a “truly significant milestone” with a Perth h...
Read ArticleThe ASX 200 posted a small 0.11 fall on Tuesday, outperformed by the small end of town as the microc...
Read ArticleMedical tech company HeraMED (HMD) raises roughly $2.39 million through a convertible note placemen...
Read ArticleIt’s been a busy morning for the ASX Healthcare sector, with plenty of positive announcements for in...
Read ArticleIt’s been a mixed week for the ASX but it has finished on a high. The ASX 200 closed 0.69% higher th...
Read ArticleLocal stocks posted a strong session on Thursday, as the ASX 200 climbed by around 1% while the micr...
Read ArticlePregnancy technology company HeraMED (HMD) enters a trading halt while it considers, plans and exec...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleHighlights Biotechnology firm Mesoblast extended its loss on disappointing earnings and dropped...
Read ArticleHighlights The ASX 200 declined as much as 1% by lunchtime as investors awaited June quarter GDP...
Read ArticleShareCafeHidden Gems Webinar Recap – EXL, WOA, OSX & HMD Catch up on the full webinar with pre...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleSummary Advanced Human Imaging has entered into a binding agreement with Jana Care to bring affo...
Read ArticleThe HeraMED Ltd (ASX: HMD) share price tanked today, closing 9% lower at 15 cents apiece. This came...
Read ArticleWhile there appeared to be several winners out of Budget 2021, few of them were on the ASX. The ASX...
Read ArticleAfter closing at a record high yesterday the ASX retreated by nearly 1 per cent today. The ASX 200 l...
Read ArticleGoogle April 2021 and the first things you’ll find isn’t ASX winners but questions about COVID-19. J...
Read ArticleSummary With the current emergency, it is anticipated that telehealth or telemedicine could be t...
Read ArticleHeraMED has announced a paid pilot with a leading medical provider for 100 expectant mothers. HeraM...
Read ArticleThe ASX fell again today, as risk-on sentiment continued to reign supreme in the markets. The ASX 20...
Read ArticleThe ASX 200 has finished the day in the red but is still above 7,000 points. The ASX 200 shed 0.68 p...
Read ArticleThe official publication of the American College of Obstetricians and Gynecologists has endorsed the...
Read ArticleSource:New Africa ,Shutterstock Summary COVID-19 had a significant impact on the HeraMED’s and...
Read ArticleSummary With COVID-19 giving the opportunity to develop products, enhance services and conduct R...
Read ArticleSummary Amid growing adoption of digital platforms, Global Health registered a robust half-year...
Read ArticleSummary Global Health Ltd (ASX:GLH) said Lifecard Patient Portal is seeing high demand as health...
Read ArticleSummary HeraMED’s partnership with eCare21 aims to fast-track awareness of HeraCARE and HeraBEAT...
Read ArticleMaternity-focused technology start-up HeraMED (ASX: HMD) has signed an agreement with US virtual car...
Read ArticleASX telehealth stocks have had a solid six months, gaining 25 per cent, but there are warnings more...
Read ArticleTelehealth use has only continued to increase as COVID-19 wore on throughout May and June. Both list...
Read ArticleSpecial Report: Maternity health digitiser HeraMED has raised serious cash from new and existing sop...
Read ArticleSpecial Report: Maternal health tech company HeraMED is preparing for clinical trials in Australia w...
Read ArticleSpecial Report: Medical tech company HeraMED has signed an exclusive deal to distribute its foetal h...
Read ArticleAs we approach the middle of 2020, the investment environment surrounding the fallout from the COVID...
Read ArticleVidCon is Stockhead’s new virtual conference series, bringing you expert insights, panel discussions...
Read ArticleSeasoned financial advisor, investment manager and corporate director Dr Nigel Finch is back in the...
Read ArticleStock Talk is a new Stockhead video series featuring a roundtable of experts discussing a new invest...
Read ArticleMaternity telehealth company HeraMED (ASX: HMD) revealed this morning in a conference call it was in...
Read ArticleHeraMED Limited (ASX:HMD), a medical technology company leading the digital transformation of matern...
Read ArticleThe coronavirus-induced market carnage of the last few weeks has rattled plenty of investor nerves....
Read ArticleSpecial Report: HeraMed’s fast-tracked development process has paid dividends as its flagship produc...
Read ArticleAnother ASX small cap has won the blessing of the Food and Drug Administration (FDA) for its product...
Read ArticleHeraMED (HMD) has appointed Alexander Radke as General Manager of its U.S. operations Alexander has...
Read Article2020 could be the year HeraMED (ASX:HMD) comes of age and it all has to do with its Artificial Intel...
Read ArticleHeraMED (HMD) has received roughly 90,000 pregnancy monitoring records from the Mayo Clinic via the...
Read ArticleMedical technology company, HeraMED Limited (ASX:HMD) has received approximately 90,000 pregnancy re...
Read ArticleAustralian health care sector is one of the fastest growing, dynamic and highly diversified sectors...
Read ArticleTechnology undoubtedly holds a significant importance in each sector of the industry, more so than e...
Read ArticleMedical technology company, HeraMED Limited (ASX:HMD) is pursuing verification around the potential...
Read ArticleThe Mayo Clinic has been established for more than 150 years, and employs more than 4500 physicians...
Read ArticleTechnology certainly plays a significant role in each segment of the industry, more so than ever, an...
Read ArticleMedical technology group, HeraMED Limited’s (ASX:HMD) distributor based in India has secured a comme...
Read ArticleHeraMED (ASX:HMD) has signed an agreement with Kinderheldin to add online midwifery service to be of...
Read ArticleThe good news keeps flowing for medical technology company, HeraMED Limited (ASX:HMD) with the compa...
Read ArticleHeraMED’s (ASX:HMD) foetal ultrasound heart rate monitor has got its long awaited green light to ent...
Read ArticleMedical technology company, HeraMED Limited’s (ASX:HMD) 510(k) application (K191110) for the company...
Read ArticleMedical data and technology developer HeraMED (ASX: HMD) has been granted key regulatory approval fo...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleEach Monday, Stockhead recaps which stocks are most heavily in demand by investors — running hot. Th...
Read ArticleWith a vision to revolutionize the pregnancy ecosystem HeraMED Limited (ASX: HMD) – an innovative me...
Read ArticleYesterday was an interesting day on the markets for HeraMED (ASX:HMD), the medtech platform which ma...
Read ArticleMedical technology group HeraMED Limited (ASX:HMD) has gone from strength to strength since listing...
Read ArticleHeraMED (ASX:HMD) has a target market of 2 million pregnancies in 2020, 6 million in 2021 and 45 mil...
Read ArticleMedical company Next Science (ASX:NXS) reiterated its US market focus in an investor presentation th...
Read ArticleMedicinal cannabis stock Althea (ASX:AGH) had a mixed bag of news for investors in its market update...
Read ArticleAustralia’s Healthcare Sector is recognised as one the best in the world with significant advances i...
Read ArticleTime is dynamic. Business is dynamic. Change might be the only constant factor but surprisingly for...
Read ArticleCV Check Ltd CV Check Ltd (ASX: CV1) is a leading online integrated screening and verification compa...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
